| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5dfc0b033ac4c841466d97a5f28ea32b |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-16 |
| filingDate |
1991-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04b5427b44d6fc9542cdfaba2fbada17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f5ce852be74a48e10f4d4692c98fc18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdcefefe2e80a591eccac0a29e9846a7 |
| publicationDate |
1993-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-H05105635-A |
| titleOfInvention |
Antiviral agent |
| abstract |
(57) [Summary] [Structure] An anti-viral agent comprising an anti-cathepsin B antibody. [Effect] The preparation of the present invention is expected as a therapeutic agent for viral diseases. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006091610-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006022409-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02094881-A3 |
| priorityDate |
1991-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |